China’s Worg Pharmaceuticals Raises ~USD58m Series B Led by Junson Capital, Lapam Capital, Kaitai Capital, Puhua Capital and Anji Ruixing Capital
Source(s): ChinaVenture
Worg Pharmaceuticals, a China-based biopharmaceutical company developing allergy and autoimmune treatments, raised a CNY400m (~USD58m) Series B led by Junson Capital, Lapam Capital, Kaitai Capital, Puhua Capital and Anji Ruixing Capital. Read more